PURPOSE: While familial aggregation of colorectal cancer (CRC) is recognized, the majority of the germline predisposition factors remain unidentified, and many high-risk CRC pedigrees remain unexplained by known risk variants. Fanconi Anemia genes have been recognized to be associated with cancer risk. Notably, FANCM (OMIM 609644) variants have been reported to confer risk for CRC and breast cancer. METHODS: Exome sequencing of CRC-affected cousins in a set of 47 independent extended high-risk CRC pedigrees identified a candidate set of rare, shared variants. Variants were tested for association with risk in 744 Utah CRC cases and 1525 controls, and for segregation with CRC in affected relatives. RESULTS: A FANCM stopgain variant was observed in two CRC-affected cousin pairs, each from an independent Utah high-risk pedigree, and yielded a nonsignificant, but elevated OR = 2.05 in a set of Utah cases and controls. Segregation of the variant to other related CRC-affected cases was observed in the two extended pedigrees. CONCLUSION: A rare stopgain variant in FANCM (rs144567652) that is recognized as a breast cancer predisposition variant, and that has previously been proposed, but not confirmed, as a CRC predisposition variant, is validated here as a risk factor for familial CRC.
PURPOSE: While familial aggregation of colorectal cancer (CRC) is recognized, the majority of the germline predisposition factors remain unidentified, and many high-risk CRC pedigrees remain unexplained by known risk variants. Fanconi Anemia genes have been recognized to be associated with cancer risk. Notably, FANCM (OMIM 609644) variants have been reported to confer risk for CRC and breast cancer. METHODS: Exome sequencing of CRC-affected cousins in a set of 47 independent extended high-risk CRC pedigrees identified a candidate set of rare, shared variants. Variants were tested for association with risk in 744 Utah CRC cases and 1525 controls, and for segregation with CRC in affected relatives. RESULTS: A FANCM stopgain variant was observed in two CRC-affected cousin pairs, each from an independent Utah high-risk pedigree, and yielded a nonsignificant, but elevated OR = 2.05 in a set of Utah cases and controls. Segregation of the variant to other related CRC-affected cases was observed in the two extended pedigrees. CONCLUSION: A rare stopgain variant in FANCM (rs144567652) that is recognized as a breast cancer predisposition variant, and that has previously been proposed, but not confirmed, as a CRC predisposition variant, is validated here as a risk factor for familial CRC.
Authors: Deborah W Neklason; Brett L Thorpe; Angel Ferrandez; Anil Tumbapura; Kenneth Boucher; Gilda Garibotti; Richard A Kerber; Cindy H Solomon; Wade S Samowitz; John C Fang; Geraldine P Mineau; Mark F Leppert; Randall W Burt; Scott K Kuwada Journal: Am J Gastroenterol Date: 2008-07-30 Impact factor: 10.864
Authors: Paolo Peterlongo; Irene Catucci; Mara Colombo; Laura Caleca; Eliseos Mucaki; Massimo Bogliolo; Maria Marin; Francesca Damiola; Loris Bernard; Valeria Pensotti; Sara Volorio; Valentina Dall'Olio; Alfons Meindl; Claus Bartram; Christian Sutter; Harald Surowy; Valérie Sornin; Marie-Gabrielle Dondon; Séverine Eon-Marchais; Dominique Stoppa-Lyonnet; Nadine Andrieu; Olga M Sinilnikova; Gillian Mitchell; Paul A James; Ella Thompson; Marina Marchetti; Cristina Verzeroli; Carmen Tartari; Gabriele Lorenzo Capone; Anna Laura Putignano; Maurizio Genuardi; Veronica Medici; Isabella Marchi; Massimo Federico; Silvia Tognazzo; Laura Matricardi; Simona Agata; Riccardo Dolcetti; Lara Della Puppa; Giulia Cini; Viviana Gismondi; Valeria Viassolo; Chiara Perfumo; Maria Antonietta Mencarelli; Margherita Baldassarri; Bernard Peissel; Gaia Roversi; Valentina Silvestri; Piera Rizzolo; Francesca Spina; Caterina Vivanet; Maria Grazia Tibiletti; Maria Adelaide Caligo; Gaetana Gambino; Stefania Tommasi; Brunella Pilato; Carlo Tondini; Chiara Corna; Bernardo Bonanni; Monica Barile; Ana Osorio; Javier Benitez; Luisa Balestrino; Laura Ottini; Siranoush Manoukian; Marco A Pierotti; Alessandra Renieri; Liliana Varesco; Fergus J Couch; Xianshu Wang; Peter Devilee; Florentine S Hilbers; Christi J van Asperen; Alessandra Viel; Marco Montagna; Laura Cortesi; Orland Diez; Judith Balmaña; Jan Hauke; Rita K Schmutzler; Laura Papi; Miguel Angel Pujana; Conxi Lázaro; Anna Falanga; Kenneth Offit; Joseph Vijai; Ian Campbell; Barbara Burwinkel; Anders Kvist; Hans Ehrencrona; Sylvie Mazoyer; Sara Pizzamiglio; Paolo Verderio; Jordi Surralles; Peter K Rogan; Paolo Radice Journal: Hum Mol Genet Date: 2015-06-30 Impact factor: 6.150
Authors: Hao Hu; Jared C Roach; Hilary Coon; Stephen L Guthery; Karl V Voelkerding; Rebecca L Margraf; Jacob D Durtschi; Sean V Tavtigian; Wilfred Wu; Paul Scheet; Shuoguo Wang; Jinchuan Xing; Gustavo Glusman; Robert Hubley; Hong Li; Vidu Garg; Barry Moore; Leroy Hood; David J Galas; Deepak Srivastava; Martin G Reese; Lynn B Jorde; Mark Yandell; Chad D Huff Journal: Nat Biotechnol Date: 2014-05-18 Impact factor: 54.908
Authors: Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly Journal: Nat Genet Date: 2011-04-10 Impact factor: 38.330
Authors: Petr Danecek; Adam Auton; Goncalo Abecasis; Cornelis A Albers; Eric Banks; Mark A DePristo; Robert E Handsaker; Gerton Lunter; Gabor T Marth; Stephen T Sherry; Gilean McVean; Richard Durbin Journal: Bioinformatics Date: 2011-06-07 Impact factor: 6.937
Authors: Francisco Javier Gracia-Aznarez; Victoria Fernandez; Guillermo Pita; Paolo Peterlongo; Orlando Dominguez; Miguel de la Hoya; Mercedes Duran; Ana Osorio; Leticia Moreno; Anna Gonzalez-Neira; Juan Manuel Rosa-Rosa; Olga Sinilnikova; Sylvie Mazoyer; John Hopper; Conchi Lazaro; Melissa Southey; Fabrice Odefrey; Siranoush Manoukian; Irene Catucci; Trinidad Caldes; Henry T Lynch; Florentine S M Hilbers; Christi J van Asperen; Hans F A Vasen; David Goldgar; Paolo Radice; Peter Devilee; Javier Benitez Journal: PLoS One Date: 2013-02-08 Impact factor: 3.240
Authors: Craig C Teerlink; Jeff Stevens; Rolando Hernandez; Julio C Facelli; Lisa A Cannon-Albright Journal: Cancer Epidemiol Date: 2021-04-28 Impact factor: 2.890